News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: March 3, 2022
“It is concerning that mortality rates for this disease are increasing,” researcher says.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: March 2, 2022
The OCM led to a statistically significant reduction in the use of denosumab – a pricier bone-modifying drug – by patients with bone...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 16, 2022
The pandemic has accelerated the use of telemedicine. The investigators wondered how it would work in patients who have achieved remission from ova...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 8, 2022
The study shows that stratifying postsurgical treatment decisions using the assay can identify patients likely to benefit from adjuvant chemotherap...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 8, 2022
The novel regimen, dubbed STRIDE, comprised a single priming dose of the investigational agent tremelimumab followed by regular doses of durvalumab...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 8, 2022
The combination of TACE and lenvatinib "represents a potential new first-line treatment option for patients with advanced HCC."
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 4, 2022
The dramatic decline in malpractice suits may have much to do with the COVID-19 pandemic, when oncology care was in a state of flux.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: February 1, 2022
An interim analysis of KEYNOTE-590 found that the combination of pembrolizumab and chemotherapy as first-line treatment, proved superior to chemoth...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: January 26, 2022
Biliary tract cancers are a relatively rare and heterogeneous group of cancers, but global incidence is rising.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: January 13, 2022
The findings may be influenced by the fact that most participants had sufficient vitamin D levels at baseline.
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: January 6, 2022
“As much as we would like to have one intervention that addresses this prominent issue, the evidence strongly suggests that cancer-related sexual p...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: January 5, 2022
“It’s low-level fraud, and not like he was laundering money or involved in pill mills, which has been problematic in Florida.”
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: January 5, 2022
Study shows that postoperative radiation therapy at 50 Gy without chemotherapy was safe and effective in a study population of intermediate-risk pa...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: December 13, 2021
Two years of adjuvant palbociclib with endocrine therapy failed to improve invasive disease-free survival in patients with stage II-III HR-positive...
News
- Author:
- Roxanne Nelson, RN, BSN
Publish date: December 10, 2021
Adjuvant treatment with metformin did not improve outcomes in most patients with early&nbs...
